Nektar Therapeutics
Price & Volume
Stats
See more52W Range | $21.02-$109 |
Market Cap | $2.3B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $55.6M |
Revenue Growth (YoY) | 3.8% |
Gross Profit (12 Mos) | $55.6M |
Diluted EPS | -$7.93 |
News
See moreYahoo Finance • 21 days ago
3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal
Yahoo Finance • last month
What Makes Nektar Therapeutics (NKTR) a Promising Mid-Cap Healthcare Stock
Yahoo Finance • 2 months ago
Russell 3000 Shuffle: Ocugen, Nektar slated to join among healthcare stocks; Nano-X to drop off
Yahoo Finance • 2 months ago
What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch
About
CEO | Mr. Howard W. Robin |
CFO | Ms. Linda M. Rubinstein M.A. |
Address | 455 Mission Bay Boulevard South, San Francisco, CA, United States, 94158 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 63 |